Trypanosoma cruzi infection suppresses nuclear factors that bind to specific sites on the interleukin
- 1 January 1994
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 24 (1) , 16-23
- https://doi.org/10.1002/eji.1830240104
Abstract
Interleukin‐2 (II‐2) gene expression, a critical early event during T lymphocyte activation, is severely suppressed in mice infected with the protozoan parasite Trypanosoma cruzi, the causative agent of human Chagas disease. Our previous observation that reduction of IL‐2 mRNA in T cells from T. cruzi‐infected mice is not due to an increased degradation of the mRNA suggests a repression of the IL‐2 gene at the transcriptional level. In this study, we have measured the level of nuclear factors that bind to specific sites on the IL‐2 enhancer. Splenocytes and splenic T cells from acutely infected mice show a marked decrease in the level of AP‐1, and a modest decrease in the level of NF‐xB and nuclear factor of activated T cells (NF‐AT). DNA‐binding activity of Oct‐1 was least affected in T cells from infected mice. Although the basal level of AP‐1 activity is comparable in cells from uninfected and infected mice, mitogen‐induced AP‐1 activation is absent in the cells from T. cruzi‐infected mice. Sodium deoxycholate treatment slightly enhances NF‐xB‐binding activity in splenocyte nuclear and whole‐cell extracts from infected mice, suggesting that a blockage of the activation of NF‐xB is only partially responsible for the decrease in the level of NF‐xB in T cells from T. cruzi‐infected mice. These data identify the molecular basis of IL‐2 gene regulation in T. cruzi infection and suggest that T cells are anergized as a result of the infection.Keywords
This publication has 26 references indexed in Scilit:
- The mechanism of action of cyclosporin A and FK506Published by Elsevier ,2003
- NF-κB Subunit Regulation in Nontransformed CD4 + T LymphocytesScience, 1992
- Nuclear factor of activated T cells contains Fos and JunNature, 1992
- The AP-1 site at -150 bp, but not the NF-kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter.The Journal of Experimental Medicine, 1992
- IP-1: A dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylationCell, 1991
- DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptideCell, 1991
- A Cell Culture Model for T Lymphocyte Clonal AnergyScience, 1990
- Regulation of Lymphokine Messenger RNA Stability by a Surface-Mediated T Cell Activation PathwayScience, 1989
- Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor OccupancyAnnual Review of Immunology, 1989
- Changes in cell populations and immunoglobulin-producing cells in the spleens of mice infected with Trypanosoma cruzi: Correlations with parasite-specific antibody responseCellular Immunology, 1983